PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-19.43%
Negative revenue growth while M7U.DE stands at 23.33%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-18.94%
Negative gross profit growth while M7U.DE is at 29.45%. Joel Greenblatt would examine cost competitiveness or demand decline.
-22.88%
Negative EBIT growth while M7U.DE is at 139.35%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
80.36%
Operating income growth at 50-75% of M7U.DE's 138.27%. Martin Whitman would doubt the firm’s ability to compete efficiently.
279.01%
Net income growth above 1.5x M7U.DE's 140.34%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
282.78%
EPS growth above 1.5x M7U.DE's 122.22%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
282.78%
Diluted EPS growth above 1.5x M7U.DE's 122.22%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-93.25%
Dividend reduction while M7U.DE stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
69.79%
OCF growth under 50% of M7U.DE's 225.75%. Michael Burry might suspect questionable revenue recognition or rising costs.
64.06%
FCF growth under 50% of M7U.DE's 199.99%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
No Data
No Data available this quarter, please select a different quarter.
53.23%
5Y revenue/share CAGR similar to M7U.DE's 52.77%. Walter Schloss might see both companies benefiting from the same mid-term trends.
45.59%
3Y revenue/share CAGR 1.25-1.5x M7U.DE's 30.86%. Bruce Berkowitz might see better product or regional expansions than the competitor.
No Data
No Data available this quarter, please select a different quarter.
146.44%
5Y OCF/share CAGR above 1.5x M7U.DE's 84.35%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
124.88%
3Y OCF/share CAGR under 50% of M7U.DE's 255.77%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
No Data
No Data available this quarter, please select a different quarter.
177.96%
5Y net income/share CAGR above 1.5x M7U.DE's 15.92%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
492.66%
3Y net income/share CAGR above 1.5x M7U.DE's 149.01%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
62.95%
Below 50% of M7U.DE's 272.06%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
60.86%
3Y equity/share CAGR at 75-90% of M7U.DE's 72.18%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
-86.62%
Negative 5Y dividend/share CAGR while M7U.DE stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-87.88%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-23.72%
Firm’s AR is declining while M7U.DE shows 26.98%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-16.60%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-4.17%
Negative asset growth while M7U.DE invests at 4.17%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
5.34%
Positive BV/share change while M7U.DE is negative. John Neff sees a clear edge over a competitor losing equity.
-11.87%
We’re deleveraging while M7U.DE stands at 10.38%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-44.21%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.